ENVOY MEDICAL, INC. (COCH)

Every figure this model derived for COCH, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 179,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 19,679,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 21,917,000 AssetsCurrent 2026-06-30
current liabilities 12,634,000 LiabilitiesCurrent 2026-06-30
equity 3,303,000 StockholdersEquity 2026-06-30
interest expense 33,000 InterestPaidNet 2026-06-30
ocf -21,533,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 207,000 Revenues 2026-06-30
sbc 804,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up COCH on one particular measure came for.

RatioValue
current ratio1.73
current ratio reported1.73
dilution pct23.8
growth cv6.56
interest cover-715.79
revenue growth-6.76
revenue growth per share-24.68
rule of 40-11417.87
sbc pct revenue388.41

What to be careful about

What this model itself distrusts about COCH's figures. Written by the derivation as it ran, not added afterwards.